The heart of Triton fund IV company Bormioli Pharma can be summed up in four words: “Small part, Big Impact”. Since becoming a stand-alone company in November 2017, the company pinpointed this very concept that animates its behaviour every day.

Bormioli Pharma, a leading pharma primary packaging manufacturer, produces "small things"  – however, these small things have a “big impact” on people’s lives. This motto is also more than just a description of what the company does, it is an important part of the company’s culture. It means striving for perfection and continuous innovation, aware that every detail matters.  

“Small part, Big Impact” can also be seen in Bormioli Pharma’s new corporate design and is also reflected in the company’s five-year strategic plan.

BORMIOLI PHARMA

Digitalisation is driving change across all sectors of the economy where Triton portfolio companies operate. Consequently, Digital Practice is a key part of Triton’s “Building Better Businesses” strategy.

Whether digital innovation involves making relatively small modifications or transforming the business model, our Digital Practice team supports our investment teams and portfolio companies in achieving their full potential and creating value.

Learn more about what Triton portfolio companies, the Digital Practice team and industry experts discussed during Triton’s 2018 Digital Day in this video.

Digital Practice
70+
investments made since 1999
260+
add-on acquisitions supported
38
companies in portfolio
€14bn
total capital commitment of 8 sponsored closed funds
  • 70+
    investments made since 1999
  • 260+
    add-on acquisitions supported
  • 38
    companies in portfolio
  • €14bn
    total capital commitment of 8 sponsored closed funds
At a glance

We know the sectors in which we are involved really well - and like to get to know potential portfolio companies years before we invest.

About us